5-Amino-1MQ 50mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the vial is provided. For research use only – not for human or veterinary use.   Product Overview 5-Amino-1MQ is a small-molecule research compound studied for its interaction with nicotinamide N-methyltransferase (NNMT) related metabolic pathways. This 50 mg lyophilized preparation is designed for controlled laboratory research into cellular energy regulation, methylation dynamics and metabolic signalling models.   Compound Overview Scientific interest in 1MQ-based compounds increased significantly between 2010 and 2025 as NNMT emerged as a relevant regulatory enzyme in cellular metabolism research. 5-Amino-1MQ is used as a reference compound for studying NNMT inhibition models, metabolic flexibility and intracellular energy balance under controlled experimental conditions.   Historical Background and Scientific Context Research into NNMT and related methyltransferase pathways expanded rapidly after 2010, driven by interest in metabolic regulation and NAD-related signalling systems. Between 2015 and 2025, 5-Amino-1MQ became a frequently referenced compound in laboratory studies exploring adipocyte metabolism, cellular energy expenditure and biochemical regulation mechanisms.   Structural & Molecular Characteristics • Chemical class: methylquinolinium derivative • Molecular type: small-molecule research compound • Structural classification: quaternary ammonium compound • Typical molecular weight: approximately 173 Da • Research focus: NNMT-related metabolic signalling   Mechanistic Focus in Research

• NNMT-related metabolic pathway modelling
• Cellular energy regulation studies
• Methylation and NAD-linked biochemical research
• Adipocyte and metabolic signalling models
• Controlled in-vitro biochemical experimentation

  Analytical Verification (COA) Independent laboratory analysis performed by Liquilabs s.r.o. (Czechia) confirms full analytical validation for this batch. Testing confirms 99.8 % purity, with assay content verified at 55.7 mg. Endotoxin levels were confirmed below 0.001 EU/mg. No detectable microbial growth was observed. Heavy metals were not detected, including arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. Identity was confirmed by chromatographic retention time and spectral validation.  

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 55.7 mg
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• NNMT-related metabolic research compound
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.